Top Markets
Coin of the day
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation

InVivo Therapeutics Holdings Corporation

NVIV
株式のランク #39771
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm,... InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
株価
$0.26
最終同期: 2024-03-11
時価総額
$356.29K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 InVivo Therapeutics Holdings Corporation (NVIV)

カテゴリー

Bの時価総額のNVIVの価格
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
NVIV
$0.26
の時価総額 InVivo Therapeutics Holdings Corporation(NVIV)
時価総額: $356.29K
August 2026時点で、InVivo Therapeutics Holdings Corporation の時価総額は $356.29K です。これは、当社のデータによると、InVivo Therapeutics Holdings Corporation が世界で39771st番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
InVivo Therapeutics Holdings Corporation の時価総額の履歴(2010 から 2026 まで)
NVIV最も人気のあるトップ5と比較stocks
NVIVの価格 資産b bの市場 結果
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$3,991,379 $356.29K
$5.470T +1,535,145,518.20%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$3,259,832 $356.29K
$4.467T +1,253,781,309.37%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$3,046,246 $356.29K
$4.174T +1,171,632,897.01%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$2,700,120 $356.29K
$3.700T +1,038,507,667.79%
InVivo Therapeutics Holdings Corporation InVivo Therapeutics Holdings Corporation
$2,082,948 $356.29K
$2.854T +801,133,718.95%